AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimavi 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Avita Laboratories Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimavi 1mg/500mg Tablet

Diabex Duo 1mg/500mg tablets are classified as antidiabetic agents, combining two medications to manage type 2 diabetes in adults. This dual-action formulation helps regulate blood glucose levels. Diabex Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is vital, even with controlled blood sugar, as discontinuation without medical consultation risks elevated glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan incorporating a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is the most frequent side effect, manifested by symptoms like sweating, dizziness, headache, and tremors. Prompt recognition and treatment are crucial; maintain regular mealtimes and carry a readily available fast-acting glucose source. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also a possibility. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or breastfeeding individuals should seek medical advice before use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to track blood cell counts and liver function.

Uses of Glimavi 1mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Glimavi 1mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. It's recommended to take Glimavi 1mg/500mg tablets with a meal.

Common Side effects of Glimavi 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimavi 1mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or dividing it. The Glimavi 1mg/500mg tablet should be administered with a meal.

How Glimavi 1mg/500mg Tablet works:

Glimepiride and metformin, combined as Glimavi 1mg/500mg tablets, offer dual action against high blood sugar. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimavi 1mg/500mg tablets with alcohol is not advised due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimavi 1mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Glimavi 1mg/500mg tablets are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use the 1mg/500mg Glimavi tablet cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Consult your physician. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimavi 1mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate hepatic dysfunction, initiation should be at a low dose; the medication is contraindicated in cases of severe liver disease.

What if you forget to take Glimavi 1mg/500mg Tablet :

Should you forget a Glimavi 1mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimavi 1mg/500mg Tablet

LabelValue
Potential for Dependence None.
Type of Treatment Medication for diabetes

FAQs on Glimavi 1mg/500mg Tablet

Maintain this medication within its original, tightly sealed container or packaging. Follow the storage guidelines provided on the packaging or label. Discard any remaining medication. Prevent access by children, pets, and others.
Glimavi 1mg/500mg Tablets may cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this is an infrequent but potentially dangerous adverse reaction to metformin, particularly risky for individuals with kidney impairment, the elderly, or those who consume significant alcohol. Symptoms can include muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, and bradycardia. Should any of these symptoms appear, discontinue Glimavi 1mg/500mg Tablet use and seek immediate medical attention.
The combination medication Glimavi, containing 1mg of Glimepiride and 500mg of Metformin per tablet, treats type 2 diabetes mellitus. In adults, it enhances glycemic control when coupled with a healthy diet and regular physical activity. Glimepiride stimulates pancreatic insulin secretion to reduce blood glucose, while Metformin decreases hepatic glucose production and improves insulin responsiveness. This dual-therapy regimen is unsuitable for managing type 1 diabetes mellitus.
Glimavi 1mg/500mg tablets may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, and headache. Serious, though infrequent, side effects such as lactic acidosis are also possible. Prolonged use might result in vitamin B12 deficiency.
Glimavi 1mg/500mg Tablet's prolonged administration can indeed lead to Vitamin B12 deficiency by disrupting its gastric absorption. This deficiency, if left unaddressed, may result in anemia, neurological complications such as tingling and numbness in the extremities, muscle weakness, urinary dysfunction, cognitive impairment, and ataxia. Prophylactic Vitamin B12 supplementation, at least annually, is recommended by some experts to mitigate these risks.
Glimavi 1mg/500mg Tablets can induce hypoglycemia, characterized by low blood sugar. Manifestations of low blood sugar may include nausea, headache, irritability, hunger, sweating, dizziness, tachycardia, and anxiety or tremors. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Always carry a readily available fast-acting carbohydrate source, such as glucose tablets, honey, or fruit juice.
Combining Glimavi 1mg/500mg tablets and alcohol is unsafe. Alcohol consumption may exacerbate hypoglycemia by further reducing blood sugar, and also raises the risk of lactic acidosis.
Glimavi 1mg/500mg Tablet
37
MRP 45
17% off